Mutsuyo Ito-Takayama
Shinjuku, 1628640, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Experimental infection of Oropouche virus in Japanese populations of Aedes albopictus and Culex mosquitoes.
Journal: Japanese journal of infectious diseases
Published: August 30, 2026
Bovine lactoferrin confers antiviral effect against La Crosse virus by interfering with virus-heparan sulfate proteoglycan binding.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: January 21, 2026
Pathological and virological findings of type I interferon receptor knockout mice upon experimental infection with Heartland virus.
Journal: Virus research
Published: October 02, 2023
Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection.
Journal: Antiviral research
Published: December 12, 2022
Genetic Characterization of Human Rabies Vaccine Strain in Japan and Rabies Viruses Related to Vaccine Development from 1940s to 1980s.
Journal: Viruses
Published: August 31, 2022
Fourth imported rabies case since the eradication of rabies in Japan in 1957.
Journal: Journal of travel medicine
Published: August 04, 2021
Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus.
Journal: PLoS neglected tropical diseases
Published: November 18, 2020
Development of an assay for detecting the residual viable virus in inactivated rabies vaccine by enzyme-linked immunosorbent assay.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: September 29, 2020
Seroprevalence of Jamestown Canyon virus in the Japanese general population.
Journal: BMC infectious diseases
Published: July 07, 2020
Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection.
Journal: Frontiers in microbiology
Published: September 30, 2019
Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
Journal: PloS one
Published: June 22, 2019
Last Updated: 09/26/2026